Palantir Just Made a Power Move

The data giant inked a deal with a company that's already deployed nationwide. It is real-world security.

Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem

Vandana Singh
July 07, 2025

Jasper Therapeutics, Inc. (NASDAQ:JSPR) stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.

What Happened?

The company reported updated data from the BEACON Phase 1b/2a study of subcutaneous briquilimab in adult chronic spontaneous urticaria (CSU) participants and provided an update on the program. It reported preliminary data in January.

The primary endpoints are briquilimab’s safety and tolerability, and the secondary endpoints are focused on clinical activity and PK/PD.

Also Read: InflaRx Ends Lead Asset Development After Failed Study For Rare And Painful Skin Disease

Primary measurements used to assess clinical activity were the sum of the Hives Severity Score and the daily Itch Severity Score (ISS), as measured via the Urticaria Activity Score over 7 days (UAS7) on a 0 to 42-point scale.

Briquilimab administration resulted in disease control in the 240mg and 360mg single-dose cohorts.

Eight of nine (89%) participants enrolled across both cohorts achieved a complete response, and seven of nine (78%) achieved a clinical response by week 2.

Reductions in UAS7 scores were reported with a mean change from baseline at 4 weeks of 28.3 points in the 240mg single-dose cohort and 22.9 points in the 360mg single-dose cohort.

In addition, BEACON participants who rolled over into the open-label extension study dosing at 180mg Q8W demonstrated clinical efficacy with 8 of 11 (73%) participants achieving a complete response at 12 weeks.

Results from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question.

The company is investigating the drug product lot in question. It expects to have the investigation results in the coming weeks.

Key observations noted in those 10 patients were lower than expected drops in mean tryptase levels and no discernable impact on UAS7 scores. The 2 participants enrolled in the cohorts that have been confirmed as being dosed with drug product from a different lot both achieved complete response.

The company also plans to enroll an additional 10-12 patients across the 240mg Q8W and the 240mg followed by 180mg Q8W cohorts to ensure a robust data set to inform the Phase 2b CSU study.

Data from the additional BEACON patients is expected in the fourth quarter of 2025, and commencement of the Phase 2b study is now expected in mid-2026.

The company has also determined that the drug product lot in question was used to treat participants enrolled in the ETESIAN trial evaluating briquilimab in asthma.

Why It Matters?

To focus resources on advancing briquilimab in CSU, the company is halting the asthma study and pausing development.

In addition, the company is halting development in SCID and will implement several other cost-cutting measures, including a potential restructuring, to extend the runway and reduce expenses.

Briquilimab treatment also resulted in deep and durable disease control in the open-label extension study evaluating briquilimab at 180mg Q8W, with 8 of 11 participants (73%) achieving a complete response at the week 12 assessment.

Substantial reductions in tryptase were observed as early as the week 1 assessment and were correlated with the onset of clinical responses. Tryptase levels below the lower limit of quantification were reported for 8 of 10 (80%) participants across the 240mg and 360mg single-dose cohorts.

Briquilimab was tolerated well in the BEACON study and the open-label extension, with no dose-limiting toxicities observed.

Price Action: JSPR stock is down 54.5% at $3.08 at the last check on Monday.

Read Next:

Photo by PeopleImages.com – Yuri A via Shutterstock

Continue Reading...

Popular

Tesla's Samsung Deal A 'Valuable Opportunity' To Gain Real-World Experience That TSMC Wouldn't Have Allowed — Experts React To $16.5 Billion Agreement

Tesla's $16.5 billion chip deal with Samsung drew strong praise from Chamath Palihapitiya, Ming-Chi Kuo, and Gene Munster, who see it as a strategic leap in AI, chip manufacturing, and Tesla's long-term autonomy ambitions.

Trump's Bitcoin Reserve Just 'Legitimized It'—Coinbase CEO Brian Armstrong Says G20 Nations Now Rushing To Build Their Own BTC Stockpiles

Coinbase Global Inc. (NASDAQ:COIN) CEO Brian Armstrong said other G20 nations are now examining Bitcoin (CRYPTO: BTC) reserves following President Donald Trump‘s establishment of a St

Palantir's Partner Is Taking Off - Ad

Palantir's stock is rising, but their new partner is moving even faster after a surprise announcement. AI meets real-world security.

Jim Cramer Made 'FAANG' Popular, Now He Says There's A New Acronym To Describe These Retail Favorite Stocks — 'PARC'

Renowned TV host Jim Cramer is stirring chatter on X with another buzzworthy "meme stock" acronym, aimed at a new group of retail-favorite stocks that are defying gravity.

Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD

Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.

The $10 Stock at the Center of Trump's $100 Trillion Move - Ad

Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Want To Bet Bigger On UnitedHealth? Now There's A Cheaper Way

New UNHG ETF offers 200% daily exposure to UnitedHealth Group with low expense ratio. Themes ETFs adds to roster with 20 single-stock leveraged ETFs.

Brace Yourself for Jeff Bezos' "Amazon Helios" - Ad

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend -- twice featured on 60 Minutes -- predicts that "Amazon Helios" will be bigger than all of those... COMBINED.

Draganfly Stock Is Moving Higher Wednesday: What's Going On?

Dragonfly shares are trading higher Wednesday after the company announced its Cammander3 XL UAV has been selected by the Department of Defense for advanced operation initiatives.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

BlackSky Technology Stock Tumbled On Tuesday: What Happened?

BlackSky Technology Inc. (NYSE: BKSY) shares fell nearly 10% on Tuesday after Canaccord Genuity cut its price target on the stock.

Elizabeth Warren Has The Receipts: 'Bribery In Plain Sight' Funding Trump's Library

Several companies have donated to President Donald Trump's future presidential library. Senator Elizabeth Warren calls this potential "bribery in plain sight."

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

EU and Japan agree to work together to promote free trade and economic security

TOKYO (AP) — Leaders of the and Japan launched an alliance Wednesday aimed at boosting economic cooperation, defending free trade and countering unfair trade practices as the two sides face growing challenges from the United States and China.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Forget 'Wealth': Warren Buffett Says This Word Is the True Measure of Success

Warren Buffett imparted his unique viewpoint on success, underscoring the significance of love and respect over the accumulation of wealth.

Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad

Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

How Trump could use a building renovation to oust the Fed chair

WASHINGTON (AP) — President says he has finally found a way to achieve his goal of removing Federal Reserve Chair Jerome Powell, accusing him of mismanaging the U.S. central bank’s $2.5 billion renovation project.

Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), describing the system as fundamentally broken and failing its intended purpose.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the August 1st funding window closes.

Pakistan urges global social media platforms to block accounts run by banned militant groups

ISLAMABAD (AP) — on Friday urged to take action to block hundreds of accounts allegedly run by outlawed militant groups that Islamabad claims spread propaganda and glorify insurgents in the South Asian country.

Trump's 'Happy Crypto Week' Gets Off To Rocky Start As House Suspends Votes On Key Bills

The House of Representatives called off Tuesday’s votes on pivotal cryptocurrency bills, citing a procedural failure.

Palantir Just Made a Power Move - Ad

The data giant inked a deal with a company that's already deployed nationwide. It is real-world security.

Anthropic Study Shows AI Chatbots Can Transfer Their Bad Habits Through Hidden Signals In Data

AI systems can pick up hidden biases from data, leading to safety concerns. Study shows this can happen even with small models sharing architecture.

Donald Trump Files $10 Billion Lawsuit Against WSJ And Rupert Murdoch

Donald Trump has filed a $10 billion defamation lawsuit against The Wall Street Journal and Rupert Murdoch.

Palantir's Partner Is Taking Off - Ad

Palantir's stock is rising, but their new partner is moving even faster after a surprise announcement. AI meets real-world security.

ASML Stock Plunges Nearly 8% In Wednesday Pre-Market: What's Going On?

Shares of Dutch semiconductor firm, ASML Holding NV (NASDAQ: ASML), has declined 7.46% during Wednesday pre-market trading, after the company expressed concerns over its 2026 growth prospects.

The $10 Stock at the Center of Trump's $100 Trillion Move - Ad

Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.

1.4M of the nation's poorest renters risk losing their homes with Trump's proposed HUD time limit

WOODINVILLE, Wash. (AP) — Havalah Hopkins rarely says no to the chain restaurant catering gigs that send her out to Seattle-area events — from church potlucks to office lunches and graduation parties.

Female HR exec caught on Coldplay cam resigns after embrace with CEO went viral

The female executive who was caught on camera embracing the CEO of her company at a Coldplay concert in a moment that went viral has resigned, according to news reports.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Carney Faces Cross-Border Pressure Amid High-Stakes US Trade Talks

Carney faces growing criticism at home as Trump threatens steep tariffs amid tense Canada-U.S. trade negotiations.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service